Vendor, Missouri City, TX
Tenaci-T Therapeutics LLC
UEI MTRTYVL8N717, CAGE 01U66
1 award and $297,621 obligated between September 16, 2025 and September 14, 2026, 100% under full and open competition, against 55.0 offers on average where reported. 2 of the awards trace back to a SAM.gov solicitation on this site.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $297,621 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Hear when Tenaci-T Therapeutics LLC wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts Tenaci-T Therapeutics LLC holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 1
- Obligated so far
- $297,621
- Soonest
- September 16, 2027
The 1 contract, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) to National Institutes of Health, by dollars.
| Leidos Biomedical Research Inc.Frederick, MD | $2,186,453,292 |
| Westat, Inc.Rockville, MD | $762,955,645 |
| Technical Resources International, Inc.Bethesda, MD | $196,391,189 |
| Duke UniversityDurham, NC | $158,758,507 |
| MriglobalKansas City, MO | $117,921,746 |
| The Johns Hopkins UniversityBaltimore, MD | $100,932,043 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N91025C00012Definitive Contract, September 16, 2025, Full and Open Competition After Exclusion of Sources, 55 offersSolicitation | NIH NCINational Institutes of Health | FY2025 SBIR Concept Clearance Award for Topic Development of Therapeutic or Preventative Technologies for Treatment or Prevention of PediatrNAICS 541715, PSC AN11 | $297,621 |
- Places of performance
- Texas
- Product and service codes
- AN11 Health R&D Services; Health Care Services; Basic Research
- Transactions
- 2 across 1 awards